BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Death Sentence for the Life Sciences? Only the Humanities Can Save
  Biomedical Research and the Pharmaceutical Industry - Don Drakeman\, Judg
 e Business School Fellow
DTSTART:20110517T170000Z
DTEND:20110517T190000Z
UID:TALK31243@talks.cam.ac.uk
CONTACT:15899
DESCRIPTION:The future of the pharmaceutical and biotechnology industries 
 – as well as academic biomedical research – depends nearly as much on 
 the humanities as on  science and medicine. Someone will have to pay for n
 ew high tech/high cost drugs if the U.K. and other countries hope to maint
 ain the economic benefits from these research intensive enterprises. Decid
 ing whether society will pay for them involves difficult questions of just
 ice\, fairness and the nature of the common good. It is essential to inves
 t in the humanities disciplines where these issues are studied\, and where
  many political leaders are educated. Failure to do so could threaten fund
 ing for corporate and academic research in the life sciences\, and impede 
 the development of new treatments for cancer and other diseases.
LOCATION:Cambridge Judge Business School\, LT3
END:VEVENT
END:VCALENDAR